| Nov 13 |
Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
|
| Aug 13 |
Virpax Pharmaceuticals GAAP EPS of -$1.75
|
| Aug 13 |
Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments
|
| Jul 29 |
Virpax Pharmaceuticals files to sell common stock, warrants
|
| Jul 24 |
Virpax regains compliance with Nasdaq minimum bid price
|
| Jul 24 |
Virpax Regains Compliance with Nasdaq Minimum Bid Price
|
| Jul 12 |
Latest Cannabis Hires And Board Changes, Here's What You Need To Know
|
| Jul 10 |
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
| Jul 10 |
Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?
|
| Jul 10 |
Virpax Announces Positive Results of Swine Model Pilot Study for Probudur™
|
